Clinical reference
Antiviral · Endonuclease inhibitor (antiviral) · Infectious Disease, Primary Care, Pediatrics
Baloxavir marboxil is an antiviral endonuclease inhibitor for influenza. Tablets: 40, 80 mg (1 tablet blister card); Oral suspension: 2 mg/mL (20 mL). Initiate treatment within 48 hr of symptom onset. Pediatric phase 3 trial (MINISONE-2) vs oseltamivir showed comparable efficacy; baloxavir well tolerated. Postexposure prophylaxis: same as treatment dose f…